Medications, Patient Education Work Together to Fight Opioid Addiction
From 2012 to 2020, VA reduced prescription opioid use in patients in its healthcare system by 64%—from 679,000 veterans to 247,000.
Clinical Pharmacists Expand Treatment of Increasing Opioid Use Disorder
The good news: The VA reduced opioid prescribing by 64% from 2012 to 2020, from more than 679,000 veterans to 247,000 through its Opioid Safety Initiative and other efforts.
US WorldMeds Becomes Partner to Battle The Opioid Epidemic During the Pandemic
Editor’s note: This information was provided by US WorldMeds and was edited for consistency and clarity, but not reported or written by U.S. Medicine staff.
While the COVID-19 pandemic continues to wreak havoc on life in the U.S., closures, staff shortages, and stay-at-home orders have greatly impacted those needing to access the healthcare system for non-COVID reasons.
Academic Detailing Pharmacists Add Pandemic Role: Telehealth Champions
For academic detailers, acting as change agents is nothing new. It’s central to their work as clinical pharmacy specialists and educators. This year, the academic detailers at the VA found their transformative role included a new and urgent responsibility—increasing provider comfort with telehealth technology.
APA Recommends Ongoing Use of Long-Acting Injectables for SMI
WASHINGTON — Even as VA facilities open up nationwide, administrators and others are keeping a wary eye on the possibility of a significant second wave of the COVID-19 pandemic in the fall. U.S. healthcare systems are preparing now for a sharp increase in cases in the...